On March 11, Carl Qin, the General Manager at CR Capital Management, and his delegation involving Ni Bing, managing director of CR Everbright Health Industry FOF, and Dr. Gong Chunhe, executive director, investigated Hunan Kexin Health Industry Group. Chen Lihong, president of Kexin Group, Hu Zhenhua and Liu Wenbo, vice presidents, and Tang Qiyong, senior consultant also accompanied in the investigation.
Qin and his delegation visited the Individualized Diagnosis and Treatment Plan Making Center, Internal Medicine of Oncology, Head, Neck and Abdomen Tumor Surgery, Expert Clinic, Oncology Prevention Department, Academician and Expert Workstation, Radiology Department, PET-CT Room, Smart Radiotherapy Department, and phase II construction site of Changsha Kexin Cancer Hospital.
Then, at the encounter for both sides, Chen Lihong, president of Kexin Group, extended a warm welcome to Qin and his delegation, and introduced in detail the general information, five-year business plan, medical technology and equipment, innovative development models and recent key projects of Kexin Group. Qin fully affirmed that Kexin Group had always been committed to the long-term goal of "Healthy China 2030", actively promoted the construction of Healthy China, continuously optimized and upgraded the health service system, and adhered to the connotative development path and achieved industry-leading development results. Both sides conducted in-depth discussions on future cooperation opportunities and related work plans.
